NCT04543188 2025-10-23A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain InvolvementPfizerPhase 1 Terminated65 enrolled 52 charts
NCT01296555 2024-07-31A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast CancerGenentech, Inc.Phase 1 Terminated674 enrolled 55 charts